Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated e...
Leadership
Claire Mazumdar Clemon M.B.A., Ph.D.
CEO & Director
Ryan Cohlhepp Pharm.D.
President, COO & Director
Ivan Hyep M.B.A.
CFO & Treasurer
Rachel Frank
Vice President of Investor Relations and Corporate Communications
